Celon Laboratories is a specialty biopharmaceutical company that focuses on research, manufacturing, and marketing of formulations in niche therapy areas of Oncology and Critical Care. With over 650 product registrations, Celon caters to 45 countries in the markets of Asia Pacific, Africa, Latin America, and some of the CIS countries. Their expertise lies in developing innovative, non-infringing, cost-effective solutions and adhering to global quality standards. Celon's work in Novel Drug Delivery Systems includes platform technologies such as Microspheres, Liposomal, and Nanoparticulate formulations. They have developed an emulsion-based drug to treat the deadly Black Fungus in COVID–19 patients. The company has received a $250 million investment to build an oral and injectables manufacturing facility for critical care and oncology. Celon provides opportunities for continuous development through regular training & development programs and fosters an environment that facilitates everyday learning.
Legal Address
Plot No.2, Aleap Industrial Estate Gajularamaram
Hyderabad; Telangana;
Postal Code: 500072
Contact Details: Purchase the Celon Laboratories Private Limited report to view the information.
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS serviceTo view more information, Request a demonstration of the EMIS service